plasmids to express: HSP90; GRP78; HSP70; HSP27, as indicated. Twenty-four h after transfection cells were treated with vehicle control or [pemetrexed (1.0 μM) + sildenafil (2 μM)] in combination for 24h. Floating cells were cytospun onto the 96 well plate and viability determined using a live / dead viability stain where green cells are viable and yellow / red cells are dead (n = 3 +/-SEM) * p < 0.05 less than the corresponding value in CMV cells; # p < 0.05 less than corresponding cells transfected to express only one chaperone. B.E. NSCLC cells were transfected with an empty vector plasmid (CMV) or plasmids to express: HSP90; GRP78; HSP70; HSP27, as indicated. Twenty-four h after transfection cells were treated with vehicle control or [pemetrexed (1.0 μM) + sildenafil (2 μM)] in combination for 6h. Cells were then fixed in place and immuno-fluorescence staining performed to determine the phosphorylation and expression of the indicated proteins. (n = 3 +/-SEM) * p < 0.05 less than the corresponding value in CMV cells; # p < 0.05 greater than corresponding value in CMV cells. F. NSCLC cells were transfected with an empty vector plasmid (CMV) or plasmids to express: HSP90; GRP78; HSP70; HSP27, as indicated. Twenty-four h after transfection cells were treated with vehicle control or [pemetrexed (1.0 μM) + sildenafil (2 μM)] in combination for 6h. Cells were then fixed in place and immuno-fluorescence staining performed to determine the phosphorylation of: mTOR S2448 (mTORC1); mTOR S2481 (mTORC2); eIF2α S51. (n = 3 +/-SEM) * p < 0.05 less than the corresponding value in CMV cells; # p < 0.05 greater than corresponding value in CMV cells.
